Mark Gillies. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Combined Modality TherapyDiabetes Mellitus, Type 1/complicationsDiabetes Mellitus, Type 2/complicationsDiabetic Retinopathy/drug therapyDiabetic Retinopathy/surgeryDiabetic Retinopathy/therapyFemaleGlucocorticoids/adverse effectsGlucocorticoids/therapeutic useHumansInjectionsLaser Coagulation/adverse effectsLaser Coagulation/methodsMacular Edema/drug therapyMacular Edema/surgeryMacular Edema/therapyMaleMiddle AgedPreservatives, PharmaceuticalRetreatmentTomography, Optical CoherenceTreatment OutcomeTriamcinolone Acetonide/adverse effectsTriamcinolone Acetonide/therapeutic useVisual Acuity/physiologyVitreous Body
Substances： See more » GlucocorticoidsPreservatives, PharmaceuticalTriamcinolone Acetonide
Year: 2009 PMID： 19264220 DOI： 10.1016/j.ophtha.2008.12.016
Source DB: PubMed Journal: Ophthalmology ISSN： 0161-6420 Impact factor: 12.079